放化疗

  • 网络Chemoradiotherapy;chemoradiation;radiochemotherapy
放化疗放化疗
  1. 食管癌新辅助放化疗结合手术与单纯手术治疗随机对照试验的Meta分析

    A Meta-Analysis of Randomized Clinical Trials ( RCTs ) that Compared Chemoradiotherapy Followed by Surgery to Surgery alone for Oesophageal Cancer

  2. 虽然绝大多数CRC患者接受了外科切除治疗和辅助放化疗,但由于患者体内存在少量难以清除的微小残留癌组织而发生复发或转移导致患者死亡。

    Although the vast majority of patients with CRC undergo radical surgical resection of tumor and adjuvant chemoradiotherapy , many still die of CRC relapse or metastasis because of the presence of the minimal residual cancer cells .

  3. 同步放化疗治疗N2、N3期鼻咽癌的临床研究

    Clinical study of concurrent radiotherapy and chemotherapy for N_2 , N_3 stage nasopharyngeal carcinoma

  4. 多层螺旋CT灌注成像评价直肠癌放化疗疗效的研究

    The study of evaluating the response of chemotherapy and radiation therapy in rectal cancer by multi-slice CT

  5. HIV阳性肛管癌患者在进行高活性抗逆转录病毒治疗的同时给予大剂量放化疗是可行的

    Anal carcinomas in HIV-positive patients : High-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy

  6. MRI新技术对肺癌靶向治疗与放化疗疗效评价的研究现状与进展

    Status and progress on therapeutic evaluation of targeted therapy , radiotherapy and chemotherapy in lung carcinoma using new MRI techniques

  7. 奥沙利铂与5-FU同步放化疗治疗局部晚期胰腺癌

    Concomitant radiochemotherapy with oxaliplatin and 5-fluorouracil for locally advanced pancreatic cancer

  8. 高聚生(SEC)联合手术放化疗治疗胶质瘤及其机制的探讨

    The Studies of SEC Therapy Combined with Radiochemotherapy on Glioma and Analysis of Treatment Mechanism

  9. 提示复方要素膳对NPC放化疗患者起到了营养支持和辅助治疗作用。

    Possesses a role of nutriment and accessory treatment on patients with NPC after chemo_radiotherapy .

  10. 研究发现,Blys的过表达是B淋巴瘤细胞快速增值及放化疗抵抗的重要原因。

    The overexpression of BlyS is a main reason for proliferation and chemotherapy resistance of B lymphoma cells .

  11. 诱导化疗组于放疗前先行PF方案化疗2周期,放疗在化疗结束后2周开始;同步放化疗组在放疗期间共进行PF方案化疗2周期。

    The patients of IC group were treated with PF 2 cycle chemotherapy 2 weeks before radiotherapy .

  12. PF方案同期放化疗与诱导放化疗治疗胸段食管癌近期疗效比较

    Comparison of the PF Project of synchronous radiotherapy and chemotherapy with induced radiotherapy and chemotherapy of thoracic esophageal cancer

  13. 为探讨加州杏仁奶对放化疗癌症患者抗氧化能力的影响,将100名准备放化疗的癌症患者随机分为A、B2组。

    The aim was to study the effect of Almond milk on antioxidant capacity in cancer patients .

  14. 同步放化疗组CR为70.21%,PR为29.79%,5年生存率57.45%;

    In radiotherapy combined with chemotherapy group CR was 70.21 % and PR was 29.79 % . The five-year survival rate was ( 57.45 % ) .

  15. 多年来应用去雄激素治疗、分子免疫、放化疗等,对晚期或进展性PCa已取得一定的疗效。

    Androgen deprivation therapy , molecular immunization , radiotherapy and chemotherapy applied for patients with advanced or metastatic PCa has made certain curative effect .

  16. 结论:ⅡB期-ⅢA期宫颈癌术前同步放化疗能使肿瘤降期,提高切除率,并不增加其近期毒副反应及手术难度。

    Conclusion : Preoperative concurrent chemoradiotherapy can make stage down and increase the rate of surgical resection for cervical cancer of FIGO stage ⅱ B ⅲ A.It dose not increase its recent toxicity and difficulty of operation .

  17. 鼻咽癌(NasopharyngealCarcinoma,NPC)是鼻咽上皮来源的恶性肿瘤,在我国具有很高的发病率,对放化疗敏感。

    Nasopharyngeal carcinoma ( Nasopharyngeal Carcinoma , NPC ) is a nasopharyngeal epithelial malignant tumor with high incidence in our country , which is sensitive to radiotherapy and chemotherapy .

  18. TP诱导化疗后同期放化疗治疗局部晚期鼻咽癌27例的Ⅱ期临床试验

    A Phase ⅱ Clinical Trial of Concurrent Chemoradiotherapy after Induction Chemotherapy with TP Regimen in the Treatment for 27 Cases with Locally Advanced Nasopharyngeal Carcinoma

  19. 研究者认为接受标准放化疗的口咽癌病人的肿瘤HPV状态与总体和无疾病进展的生存率强烈相关。

    The investigators concluded that tumor HPV status is strongly associated with overall and progression-free survival among oropharyngeal cancer patients receiving standard of care chemoradiation .

  20. 两种国产rhG-CSF治疗放化疗后白细胞减少最小成本分析

    Cost-minimization Analysis of Two kinds of Domestic rhG-CSF Schemes on Patients with Leukopenia after Radiotherapy and Chemotherapy

  21. 传统的放化疗治疗AML完全缓解率较低,易复发。

    The complete remission rate is significantly lower and relapsed quickly in the AML cases that were treated by traditional chemo-therapy and radio-therapy .

  22. [结论]对于NSCLC,后程调强适形序贯放化疗与常规序贯放化疗疗效相近,毒性反应未增加。

    [ Conclusions ] The efficacy of sequential chemotherapy and boost IMRT is close to conventional sequential radiotherapy and chemotherapy for NSCLC without increasing toxicity .

  23. 目的:探讨18F标记的脱氧葡萄糖(18F-FDG)正电子发射型计算机断层显像(PET)在肺癌治疗中对肺癌放化疗效果的价值。

    Objective : To assess the result of radiotherapy and chemotherapy in the treatment of lung cancer with 18 F-FDG PET imaging .

  24. DNA-PK作为放化疗增敏靶点的研究进展

    DNA-PK as the target for enhancing sensitivity of radiotherapy and chemotherapy

  25. 目的:造血干细胞移植(Hematopoieticstemcelltransplantation,HSCT)是治疗恶性血液病、放化疗敏感的实体肿瘤以及急性放射病的重要手段。

    Objective : Hematopoietic stem cell transplantation ( HSCT ) is a very important method for curing hematologic malignancy and some solid carcinomas sensitive to radiotherapy / chemotherapy , as well as acute radiation diseases .

  26. COX回归模型分析结果:在诸多影响结直肠多原发癌的预后中因素中手术方式、TNM临床分期、放化疗为主的综合治疗是主要的独立因素。

    The COX regression model analysis shows that the operation types , TNM stages and integrated treatment are the main independent factors among all the related prognostic factors .

  27. 方法:运用荧光定量PCR技术(real-timePcR)动态检测22例单纯放疗及14例同期放化疗鼻咽癌患者治疗期间血浆EBVDNA水平。

    Methods : Using Real-Time PCR technique , the concentrations of plasma EBV DNA were analyzed weekly during treatment in 22 NPC patients treated with radiotherapy alone , and 14 NPC patients treated with combined radiotherapy and concurrent chemotherapy .

  28. 目的探讨冻干人胎盘因子(PF)对放化疗患者生活质量的影响。

    Objective To evaluate the effect of lyophilized human placenta factor ( PF ) on quality of life ( QOL ) of patients with solid tumor treated with radiotherapy or chemotherapy .

  29. 在浸润性宫颈癌中,术前放化疗对Ang-1表达无显著影响。

    In the invasive cervical cancer , preoperative radiotherapy and chemotherapy on Ang-1 expression had no significant effects . 4 .

  30. 放化疗结合76例,2GY×30天;

    Radiotherapy ( 60GY ; 2GY / d ) combined with chemotherapy , 76 patients ;